Founded in 2017 after demerging from Actelion, Idorsia Pharmaceuticals develops and commercializes innovative medicines from its scientific base near Basel, Switzerland. Its discovery engine pursues novel drug mechanisms across several disease areas, while its bench-to-bedside work has produced marketed treatments including QUVIVIQ for insomnia and TRYVIO/JERAYGO for hypertension. The company’s roughly 500 employees also develop synthetic glycoconjugate vaccines and advance medicines through a network of strategic partnerships.
IpsenFounded in 1929 as a family business, Ipsen develops and brings pharmaceutical medicines to patients with significant unmet medical needs. The global biopharmaceutical company has more than 5,000 employees and concentrates its research and portfolio on oncology, rare disease and neuroscience, with products registered in 88 countries. Its history includes early manufacturing in France and a long-standing focus on translating scientific discovery into scalable, patient-ready treatments.BERKELEY HEIGHTS 07922, NY
IDT BiologikaFounded in 1921, IDT Biologika is a Dessau-Rosslau-based global CDMO that develops and manufactures vaccines, viral vectors, biologics and sterile injectables from early development through commercial supply. Its particular strength is more than a century of experience working with live viruses, supported by BSL-2 facilities, integrated process development and manufacturing, and in-house quality and analytical services. Now part of SK bioscience, the company employs about 1,600 people and serves pharmaceutical and biotechnology customers as well as governments worldwide.ROCKVILLE, MD
pharmaand GmbH (pharma&)Founded in Vienna in 2017, privately owned pharma& acquires, develops, manufactures, and supplies proven specialty medicines whose availability is important to patients worldwide. With nearly 400 industry experts and operations spanning Europe, the United States, and Canada, the company combines pharmaceutical development with in-house API production and packaging. Its Austrian subsidiary Loba biotech makes the active ingredient for Pegasys®, while pharma& continues expanding its focus on hematology and oncology.New York, NY
LonzaFounded in Switzerland in 1897, Lonza is a global contract development and manufacturing organization that helps pharmaceutical and biotechnology companies turn new medicines into clinical and commercial therapies. Its network of more than 30 sites and approximately 19,000 employees spans five continents, with capabilities ranging from biologics and small-molecule drug products to cell and gene therapies and mRNA manufacturing. In Bend, Oregon, the former Bend Research team brings more than 45 years of specialized experience in improving drug solubility and bioavailability.WALKERSVILLE, MD